18 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 18 separate news trends connected to Multiple Sclerosis, spanning June 25, 2026 through November 6, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 186 article observations and 158 source signals, led by Entertainment, Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
5 news sources are covering this Entertainment story right now — Archynetys is tracking how fast it spreads.
A Hollywood star’s misdiagnosed MS battle sparks a wider look at diagnostic errors and personal resilience.
7 news sources are covering this Entertainment story right now — Archynetys is tracking how fast it spreads.
A fatal infection in Bristol Myers’ autoimmune CAR‑T trial upends expectations for a promising multiple‑sclerosis therapy
Bristol Myers faces safety concerns in CAR-T trials after patient death
6 news sources are covering this Entertainment story right now — Archynetys is tracking how fast it spreads.
Megyn Kelly’s ‘fungus’ jab at Christina Applegate’s MS diagnosis ignites backlash from a former friend and TV hosts
Moderna-Merck cancer vaccine data reveal promising results for high-risk melanoma patients.
Roche’s MS pill slashes relapses by 55%, fueling a blockbuster BTK bid as an FDA decision looms.
Cold sore virus may reprogram brain's immune defenses
Actress Christina Applegate reveals she was misdiagnosed with multiple sclerosis.
Experimental drug shows promise in reversing multiple sclerosis symptoms
A single cellular blueprint now links five debilitating fatigue disorders, opening doors for unified therapies.
Two positive Phase III results for an oral multiple sclerosis drug have pushed Novartis forward in a competitive pharmaceutical market.
Novartis’s Rhapsido clears two Phase III hurdles, sending its stock soaring.
England's NHS begins offering a drug that improves mobility for multiple sclerosis patients.
New biological research identifies specific Epstein-Barr virus components linked to the development of multiple sclerosis.
Janice Dean is retiring from Fox News after 22 years as a meteorologist due to worsening MS symptoms.